TOKYO -- Fujifilm Holdings is staking its future on becoming a provider of drug development and manufacturing services to other pharmaceutical companies.
Health Care
Fujifilm to spend $5bn to become global contract drugmaker
Opportunity seen in outsourcing trend similar to chip industry
Fujifilm plans to introduce a new production system that can produce antibodies with high purity more efficiently at its plant in the U.K. (Photo courtesy of Fujifilm)
Read Next
Latest on Health Care
